📰 Clinically Utilized News
Page 3 - Clinically Utilized News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinically Utilized. Real-time updates on events, politics, business and more.
May 12, 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) will present 46 abstracts across eight types of cancer during the upcoming American Society of Clinical Oncology (ASCO)...
May 12, 2022
Multiple epcoritamab (DuoBody-CD3xCD20) studies will be presented showcasing preliminary efficacy and safety findings in a variety of patient populations in need of treatment options Several
April 14, 2022
Company AnnouncementBased on the topline results from the EPCORE™ NHL-1 clinical trial, Genmab and AbbVie will engage global regulatory authorities to discuss next stepsData from the clinical trial to be presented at a future medical meetingLarge B-cell lymphoma (LBCL) is a common form of non-Hodgkin’s lymphoma (NHL...
April 14, 2022
Company Announcement Based on the topline results from the EPCORE™ NHL-1 clinical trial, Genmab and AbbVie will engage global regulatory authorities t
April 13, 2022
Company Announcement Based on the topline results from the EPCORE™ NHL-1 clinical trial, Genmab and AbbVie will engage global regulatory authorities to...
April 13, 2022
Company Announcement Based on the topline results from the EPCORE NHL-1 clinical trial, Genmab and AbbVie will engage global regulatory authorities to discuss next steps Data from the clinical
April 13, 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) and Genmab A/S (Nasdaq: GMAB) today announced topline results from the first cohort of the EPCORE™ NHL-1 phase 1/2 clinical...
November 4, 2021
ABBVie will present results from nearly 30 abstracts across eight types of cancer during the upcoming American Society of Hematology Annual Meeting in Atlanta, Georgia . "We are dedicated to transforming standards of care for people living with blood cancers," said Mohamed Zaki M.D., Ph.D, vice president and global head of oncology development, AbbVie. "The data we are presenting at the ASH Annual Meeting build on ...
November 4, 2021
Poster presentations highlighting safety and preliminary efficacy data of epcoritamab (DuoBody-CD3xCD20) in combination with other treatments in patients with B-cell non-Hodgkin lymphoma (NHL)
November 4, 2021
/PRNewswire/ -- AbbVie (NYSE: ABBV) will present results from nearly 30 abstracts across eight types of cancer during the upcoming American Society of...